Author response for 'Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant'

Authors :: Carolina Terragna
Francesco Barbato
F Bonifazi
Simona Soverini
Jacopo Nanni
Elisabetta Zappone
Sarah Parisi
Mario Arpinati
Gianluca Cristiano
Antonio Curti
Chiara Sartor
Gabriella Chirumbolo
Michele Cavo
Alida Dominietto
Valentina Robustelli
Giovanni Marconi
Cristina Papayannidis
Nicoletta Testoni
Stefania Paolini
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Inotuzumab ozogamicin
business.industry
Lymphoblastic Leukemia
Cancer research
Medicine
Stem cell
business
Donor lymphocyte infusion
medicine.drug

Full Text Access

Tools